Amlodipine Besylate Tablet
Product Images NDC 68071-1980

4 FDA label images from Nucare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68071-1980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 1980 6

68071 1980 6
A rectangular pharmaceutical label for Amlodipine Besylate 10 mg tablets by NuCare Pharmaceuticals, Inc. The label states a quantity of 60 tablets, described as round white/off-white and debossed with '128' on one side and 'C' on the other. It includes the product number P1707060, NDC 68071-1980-6, and storage instructions for controlled temperature (68-77°F). Additional regulatory and manufacturing details appear including warnings and a QR code.*
FDA Label Image

Image (8e9a1a44 678c 4422 99d4 D0847248bd8e 01)

Image (8e9a1a44 678c 4422 99d4 D0847248bd8e 01)
Chemical structure of amlodipine besylate, depicted as a two-dimensional molecular diagram showing rings, substituents, and functional groups including chlorine and amino groups.*
FDA Label Image

Image2 (8e9a1a44 678c 4422 99d4 D0847248bd8e 02)

Image2 (8e9a1a44 678c 4422 99d4 D0847248bd8e 02)
A Kaplan-Meier curve comparing event rates over time (in months) between Amlodipine and Placebo groups. The graph includes a p-value (0.003), hazard ratio (0.691), and 95% confidence interval (0.54, 0.88), with the number of subjects at risk shown at various time points up to 24 months.*
FDA Label Image

Image3 (8e9a1a44 678c 4422 99d4 D0847248bd8e 03)

Image3 (8e9a1a44 678c 4422 99d4 D0847248bd8e 03)
A forest plot illustrating hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine to placebo. Subgroups include overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis is labeled "Hazard Ratio (95% Confidence Interval)" ranging from 0.0 to 2.0, indicating favor towards Amlodipine on the left and placebo on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.